Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Eisai CO Ltd ADR (ESALY)

Eisai CO Ltd ADR (ESALY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 20,744,860
  • Shares Outstanding, K 296,567
  • Annual Sales, $ 5,786 M
  • Annual Income, $ 570,470 K
  • 60-Month Beta 0.54
  • Price/Sales 3.60
  • Price/Cash Flow 24.80
  • Price/Book 3.42
  • Price/Earnings ttm 38.84
  • Earnings Per Share ttm 1.81
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 03/30/20
  • Annual Dividend & Yield 1.24 (1.78%)
  • Most Recent Dividend 0.621 on 09/26/19
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year 0.23
  • Growth Rate Est. (year over year) +434,247.83%

Price Performance

See More
Period Period Low Period High Performance
1-Month
54.0000 +29.54%
on 03/19/20
76.9100 -9.05%
on 03/05/20
-3.5800 (-4.87%)
since 02/27/20
3-Month
54.0000 +29.54%
on 03/19/20
90.8200 -22.98%
on 02/05/20
-6.2250 (-8.17%)
since 12/27/19
52-Week
48.5200 +44.17%
on 09/04/19
90.8200 -22.98%
on 02/05/20
+14.3400 (+25.79%)
since 03/27/19

Most Recent Stories

More News
Xencor (XNCR) Jumps: Stock Rises 7.4%

Xencor (XNCR) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

XNCR : 28.46 (-6.04%)
ESALY : 69.9500 (-0.50%)
The Zacks Analyst Blog Highlights: Eisai, Martin Marietta and Columbia Sportswear

The Zacks Analyst Blog Highlights: Eisai, Martin Marietta and Columbia Sportswear

MLM : 181.22 (-7.03%)
ESALY : 69.9500 (-0.50%)
COLM : 67.74 (-3.91%)
Ocular (OCUL) Gets FDA Nod for Label Expansion of Dextenza

Ocular (OCUL) clinches the FDA approval for the label expansion of Dextenza to treat ocular inflammation following ophthalmic surgery.

REGN : 449.52 (-0.61%)
AERI : 13.05 (-3.33%)
OCUL : 4.92 (+0.82%)
ESALY : 69.9500 (-0.50%)
Pape Diop propose des formes de financements innovants

"Les communes et autres collectivités locales doivent réfléchir sur les modalités d'augmenter leur budget en recourant à des financements innovants", a dit samedi à Louga, Pape Diop.

CannTrust Holdings (CTST) in Focus: Stock Moves 6.1% Higher

CannTrust Holdings (CTST) saw a big move last session, as its shares jumped more than 6% on the day, amid huge volumes.

ESALY : 69.9500 (-0.50%)
CTST : 0.7020 (-5.14%)
Catalyst (CPRX) Q1 Loss Narrows, Firdapse Off to a Good Start

Catalyst (CPRX) posts narrower-than-expected loss and beats on revenues in the first quarter of 2019.

BSTC : 51.50 (-2.99%)
CPRX : 3.77 (-3.08%)
REPH : 6.64 (-13.43%)
ESALY : 69.9500 (-0.50%)
Zoetis (ZTS) Earnings Beat Estimates in Q1, Revenues Miss

Zoetis???s (ZTS) earnings beat estimates but sales miss the same in the first quarter of 2019.

ZTS : 111.77 (-5.21%)
ESALY : 69.9500 (-0.50%)
FGEN : 33.47 (-1.03%)
BSTC : 51.50 (-2.99%)
Achaogen (AKAO) Files for Bankruptcy, Shares Plunge 65%

Achaogen (AKAO) files for bankruptcy in a district court. Shares slump 65% on the announcement.

ESALY : 69.9500 (-0.50%)
BSTC : 51.50 (-2.99%)
AKAO : 0.11 (unch)
ASRT : 0.6501 (-8.15%)
Zogenix Gets Refusal to File Letter From FDA for Seizure Drug

Zogenix (ZGNX) receives a Refusal to File letter from the FDA regarding its NDA for Fintepla for the treatment of seizures associated with Dravet syndrome.

GWPH : 85.75 (-0.94%)
ZGNX : 23.36 (-1.27%)
BSTC : 51.50 (-2.99%)
ESALY : 69.9500 (-0.50%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Trade ESALY with:

Key Turning Points

2nd Resistance Point 74.9500
1st Resistance Point 72.4500
Last Price 69.9500
1st Support Level 68.5500
2nd Support Level 67.1500

See More

52-Week High 90.8200
Fibonacci 61.8% 74.6614
Last Price 69.9500
Fibonacci 50% 69.6700
Fibonacci 38.2% 64.6786
52-Week Low 48.5200

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar